Evidence map›Paper›PMID 41647216›Full record

ArticleArXiv2026

Charting the velocity of brain growth and development.

Johanna M M Bayer, Augustijn A A de Boer, Barbora Rehák-Bučková, Charlotte J Fraza, Tobias Banaschewski, Gareth J Barker, Arun L W Bokde, Rüdiger Brühl, Sylvane Desrivières, Herta Flor and 23 more

Abstract readPreprint
In one paragraph

Article in ArXiv, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Johanna M M BayerDonders Institute for Brain, Cognition and Behaviour, Kapittelweg 29, Nijmegen, 6511SK, Gelderland, The Netherlands.
Augustijn A A de BoerDonders Institute for Brain, Cognition and Behaviour, Kapittelweg 29, Nijmegen, 6511SK, Gelderland, The Netherlands.
Barbora Rehák-BučkováDonders Institute for Brain, Cognition and Behaviour, Kapittelweg 29, Nijmegen, 6511SK, Gelderland, The Netherlands.
Charlotte J FrazaDonders Institute for Brain, Cognition and Behaviour, Kapittelweg 29, Nijmegen, 6511SK, Gelderland, The Netherlands.
Tobias BanaschewskiDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159 Mannheim, Germany.
Gareth J BarkerDepartment of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King's College London, United Kingdom.
Arun L W BokdeDiscipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.
Rüdiger BrühlPhysikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Germany.
Sylvane DesrivièresSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, United Kingdom.
Herta FlorInstitute of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.
Hugh GaravanDepartment of Psychology, School of Social Sciences, University of Mannheim, 68131 Mannheim, Germany.
Penny GowlandDepartments of Psychiatry and Psychology, University of Vermont, 05405 Burlington, Vermont, USA.
Antoine GrigisSir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, United Kingdom.
Andreas HeinzDepartment of Psychiatry and Psychotherapy, University of Tübingen, Germany; German Center for Mental Health (DZPG), Site Tübingen, Germany.
Herve LemaitreInstitut des Maladies Neurodégénératives, UMR 5293, CNRS, CEA, Université de Bordeaux, 33076 Bordeaux, France.
Jean-Luc MartinotInstitut National de la Santé et de la Recherche Médicale, INSERM U 1299 "Developmental Trajectories, Psychiatry & Addictology", University Paris-Saclay, Ecole Normale Supérieure Paris-Saclay, Dept. mathematics, CNRS UMR9010; Centre Borelli, Gif-sur-Yvette, France.
Marie-Laure Paillère MartinotInstitut National de la Santé et de la Recherche Médicale, INSERM U 1299 "Developmental Trajectories, Psychiatry & Addictology", University Paris-Saclay, Ecole Normale Supérieure Paris-Saclay, Dept. mathematics, CNRS UMR9010; Centre Borelli, Gif-sur-Yvette, France.
Eric ArtiguesInstitut National de la Santé et de la Recherche Médicale, INSERM U 1299 "Developmental Trajectories, Psychiatry & Addictology", University Paris-Saclay, Ecole Normale Supérieure Paris-Saclay, Dept. mathematics, CNRS UMR9010; Centre Borelli, Gif-sur-Yvette, France.
Frauke NeesInstitute of Medical Psychology, Ludwig-Maximilians-Universität (LMU) in Munich, Munich, Germany.
Dimitri Papadopoulos OrfanosNeuroSpin, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France.
Tomáš PausDepartment of Psychiatry, Faculty of Medicine and Centre Hospitalier Universitaire Sainte-Justine, University of Montreal, Montreal, Quebec, Canada.
Luise PoustkaDepartment of Child and Adolescent Psychiatry, Center for Psychosocial Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Michael N SmolkaDepartment of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany.
Nathalie HolzDonders Institute for Brain, Cognition and Behaviour, Kapittelweg 29, Nijmegen, 6511SK, Gelderland, The Netherlands.
Nilakshi VaidyaCentre for Population Neuroscience and Stratified Medicine (PONS), Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Germany.
Henrik WalterDepartment of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Robert WhelanSchool of Psychology and Global Brain Health Institute, Trinity College Dublin, Ireland.
Paul WirschingDepartment of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Gunter SchumannCentre for Population Neuroscience and Stratified Medicine (PONS), Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Germany.
Alzheimer’s Disease Neuroimaging Initiative
Nina KraguljacOhio State College of Medicine, Columbus, Ohio, USA.
Christian F BeckmannDonders Institute for Brain, Cognition and Behaviour, Kapittelweg 29, Nijmegen, 6511SK, Gelderland, The Netherlands.
Andre F MarquandDonders Institute for Brain, Cognition and Behaviour, Kapittelweg 29, Nijmegen, 6511SK, Gelderland, The Netherlands.

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

Brain charts have emerged as a highly useful approach for understanding brain development and aging on the basis of brain imaging and have shown substantial utility in describing typical and atypical brain development with respect to a given reference model. However, all existing models are fundamentally cross-sectional and cannot capture change over time at the individual level. We address this using velocity centiles, which directly map change over time and can be overlaid onto cross-sectionally derived population centiles. We demonstrate this by modelling rates of change for 24,062 scans from 10,795 healthy individuals with up to 8 longitudinal measurements across the lifespan. We provide a method to detect individual deviations from a stable trajectory, generalising the notion of 'thrive lines', which are used in pediatric medicine to declare 'failure to thrive'. Using this approach, we predict transition from mild cognitive impairment to dementia more accurately than by using either time point alone, replicated across two datasets. Last, by taking into account multiple time points, we improve the sensitivity of velocity models for predicting the future trajectory of brain change. This highlights the value of predicting change over time and makes a fundamental step towards precision medicine.

Indexed as

longitudinalnormative modellingthrive linevelocity centile

Identifiers

PMID41647216
PMCPMC12869400

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.